Evaluation of EMLA cream for relieving pain during needle insertion on totally implantable venous access device.

CONCLUSION: The present results review that the application of EMLA cream for 30 min is suitable, acceptable, and convenient in cancer patients with totally implantable venous access device undergoing needle insertion. PMID: 29629603 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29629603?dopt=Abstract

Source: The Journal of Vascular Access - April 10, 2018 Category: Surgery Tags: J Vasc Access Source Type: research